World's Best Scientists 2026 revealed!
VIEW LIST
Christine Chevreau

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 86 13914 13101 7061 6536 512 36526

Christine Chevreau publications per year

The chart shows the history of publications by Christine Chevreau between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christine Chevreau published across 39 years, from 1987 to 2025, averaging 14.2 papers a year. Output peaked at 59 publications in 2023. 13 of the 553 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 59. Peak 59 publications in 2023. 1987: 1 publication 1988: 0 publications 1989: 6 publications 1990: 2 publications 1991: 3 publications 1992: 3 publications 1993: 5 publications 1994: 6 publications 1995: 6 publications 1996: 5 publications 1997: 4 publications 1998: 12 publications 1999: 6 publications 2000: 4 publications 2001: 5 publications 2002: 7 publications 2003: 5 publications 2004: 10 publications 2005: 7 publications 2006: 5 publications 2007: 18 publications 2008: 12 publications 2009: 15 publications 2010: 12 publications 2011: 26 publications 2012: 24 publications 2013: 20 publications 2014: 35 publications 2015: 16 publications 2016: 26 publications 2017: 31 publications 2018: 24 publications 2019: 24 publications 2020: 39 publications 2021: 41 publications 2022: 16 publications 2023: 59 publications 2024: 6 publications 2025: 7 publications
1987 2025

553 publications in total across all disciplines

View publications per year as a table
Christine Chevreau: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 6
1990 2
1991 3
1992 3
1993 5
1994 6
1995 6
1996 5
1997 4
1998 12
1999 6
2000 4
2001 5
2002 7
2003 5
2004 10
2005 7
2006 5
2007 18
2008 12
2009 15
2010 12
2011 26
2012 24
2013 20
2014 35
2015 16
2016 26
2017 31
2018 24
2019 24
2020 39
2021 41
2022 16
2023 59
2024 6
2025 7
Total 553
Download as CSV

Christine Chevreau publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christine Chevreau sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 501–520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 512 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617 512
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Christine Chevreau D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christine Chevreau sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 86
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Christine Chevreau is affiliated with DuPont in the United States. Their research primarily focuses on medicine, with significant contributions across several subfields including pulmonary and respiratory medicine, oncology, surgery, rheumatology, and pathology and forensic medicine.

The scientist has published an extensive number of papers, with the main fields of study encompassing:

  • Medicine

They have worked extensively on topics related to cancer and related treatments. The main areas of research interest include:

  • Sarcoma Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Cancer Immunotherapy and Biomarkers
  • Vascular Tumors and Angiosarcomas
  • Cancer Genomics and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Cardiac tumors and thrombi

Christine Chevreau's work has appeared in a number of frequently featured publication venues such as:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • The Lancet Oncology
  • Cancers

They have collaborated regularly with other researchers, including:

  • Jean-Yves Blay
  • Emmanuelle Bompas
  • Nicolas Penel
  • Sophie Piperno-Neumann
  • Florence Duffaud

Among the recent papers associated with the broader research themes of this scientist are:

  • Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma, 2021, New England Journal of Medicine
  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial, 2020, The Lancet Oncology
  • Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial, 2020, Cancer
  • Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial, 2022, The Lancet Oncology

Best Publications

  • Sorafenib in advanced clear-cell renal-cell carcinoma.

    Bernard Escudier;Tim Eisen;Walter M. Stadler;Cezary Szczylik

  • Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

    Bernard Escudier;Anna Pluzanska;Piotr Koralewski;Alain Ravaud

  • Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

    Bernard Escudier;Tim Eisen;Walter M. Stadler;Cezary Szczylik

  • Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

    Sylvie Negrier;Bernard Escudier;Christine Lasset;Jean-Yves Douillard

  • Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Andrés J M Ferreri;Jean Yves Blay;Michele Reni;Felice Pasini

  • Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

    Arnaud Méjean;Alain Ravaud;Simon Thezenas;Sandra Colas

  • Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

    Nicolas Penel;Binh Nguyen Bui;Jacques-Olivier Bay;Didier Cupissol

  • Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

    Joaquim Bellmunt;Hans von der Maase;Graham M. Mead;Iwona Skoneczna

  • Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

    Toni K. Choueiri;Piotr Tomczak;Se Hoon Park;Balaji Venugopal

  • High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

    J Y Blay;T Conroy;C Chevreau;A Thyss

  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

    Thomas Powles;Michiel S van der Heijden;Daniel Castellano;Matthew D Galsky

  • Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie

    S. Négrier;B. Escudier;F. Gomez;J.-Y. Douillard

  • Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

    Maud Toulmonde;Nicolas Penel;Julien Adam;Julien Adam;Christine Chevreau

  • Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.

    M de Forni;Myriam Malet-Martino;P Jaillais;R Shubinski

  • Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient Characteristics

    Etienne Chatelut;Pierre Canal;Valérie Brunner;Christine Chevreau

  • Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial

    Axel Le Cesne;Isabelle Ray-Coquard;Binh Nguyen Bui;Antoine Adenis

  • Improved survival using specialized multidisciplinary board in sarcoma patients.

    J.-Y. Blay;P. Soibinet;N. Penel;E. Bompas

  • Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

    Sylvie Négrier;Gwenaëlle Gravis;David Pérol;Christine Chevreau

  • Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.

    Florence Duffaud;Olivier Mir;Pascaline Boudou-Rouquette;Sophie Piperno-Neumann

  • Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.

    N. Penel;A. Le Cesne;B.N. Bui;D. Perol

Frequent Co-Authors

Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
François Bertucci
François Bertucci Aix-Marseille University
Axel Le Cesne
Axel Le Cesne Institut Gustave Roussy
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
Antoine Italiano
Antoine Italiano University of Bordeaux
Isabelle Ray-Coquard
Isabelle Ray-Coquard Claude Bernard University Lyon 1
Alain Ravaud
Alain Ravaud University of Bordeaux
Stéphane Oudard
Stéphane Oudard Hôpital Européen Georges-Pompidou
Laurence Albiges
Laurence Albiges Institut Gustave Roussy
Karim Fizazi
Karim Fizazi University of Paris-Saclay

External Links

Personal website of Christine Chevreau

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s valuable to explore related online degrees and alternative career pathways that support the healthcare ecosystem. These flexible academic options can help you start or advance your medical career based on your interests and goals.

For those looking to become nurses quickly and without the stress of strict admission exams, you can find an lpn program no entrance exam. This can be a practical entry point into nursing, offering a more streamlined admission process.

If you’re interested in the administrative side of healthcare, accredited online health administration programs allow you to develop leadership skills and pursue roles in management, policy, and organization within medical settings.

Already an RN? Accelerate your career with rn to fnp bridge programs, which enable registered nurses to earn their advanced practice credentials and become Family Nurse Practitioners in less time.

Those passionate about wellness and preventive care can earn a bachelor's in nutrition online, opening doors to careers in dietetics, research, and health education.

These related online degrees offer flexible, accessible ways to enter or grow within the healthcare field, catering to a wide range of interests and career ambitions.

Best Scientists Citing Christine Chevreau

Bernard Escudier

Bernard Escudier

Institut Gustave Roussy

Publications: 183

Brian I. Rini

Brian I. Rini

Vanderbilt University Medical Center

Publications: 149

Jean-Yves Blay

Jean-Yves Blay

Claude Bernard University Lyon 1

Publications: 148

Toni K. Choueiri

Toni K. Choueiri

Harvard University

Publications: 148

Robert J. Motzer

Robert J. Motzer

Memorial Sloan Kettering Cancer Center

Publications: 142

Camillo Porta

Camillo Porta

University of Bari Aldo Moro

Publications: 116

Joaquim Bellmunt

Joaquim Bellmunt

Beth Israel Deaconess Medical Center

Publications: 99

Ronald M. Bukowski

Ronald M. Bukowski

Cleveland Clinic

Publications: 97

Alain Ravaud

Alain Ravaud

University of Bordeaux

Publications: 84

Thomas E. Hutson

Thomas E. Hutson

Texas Oncology

Publications: 82

Thomas Powles

Thomas Powles

Queen Mary University of London

Publications: 80

Alessandro Gronchi

Alessandro Gronchi

University of Milan

Publications: 80

David F. McDermott

David F. McDermott

Beth Israel Deaconess Medical Center

Publications: 79

Cora N. Sternberg

Cora N. Sternberg

Cornell University

Publications: 78

Laurence Albiges

Laurence Albiges

Institut Gustave Roussy

Publications: 76

Eric Jonasch

Eric Jonasch

The University of Texas MD Anderson Cancer Center

Publications: 68

Trending Scientists

Yu Luo

Yu Luo

Nanyang Technological University

David A. Wolk

David A. Wolk

University of Pennsylvania

Shingo Watanabe

Shingo Watanabe

Japan Agency for Marine-Earth Science and Technology

Donald B. Kohn

Donald B. Kohn

University of California, Los Angeles

Martin Petkovich

Martin Petkovich

Queen's University

Andreas Möller

Andreas Möller

QIMR Berghofer Medical Research Institute

Po Sing Leung

Po Sing Leung

Chinese University of Hong Kong

Iiris Hovatta

Iiris Hovatta

University of Helsinki

Zach W. Hall

Zach W. Hall

University of California, San Francisco

Margaret K. Tivey

Margaret K. Tivey

Woods Hole Oceanographic Institution

Omar Lizardo

Omar Lizardo

University of California, Los Angeles

Erkka Valovirta

Erkka Valovirta

University of Turku

Richard L. McCreery

Richard L. McCreery

University of Alberta

Alan de Brauw

Alan de Brauw

International Food Policy Research Institute

Philip S. Wang

Philip S. Wang

Harvard Medical School

Kiona Ogle

Kiona Ogle

Northern Arizona University

Related Medicine Rankings & Guides

2027 Easiest Medical Degree Programs

2027 Easiest Medical Degree Programs
2027 Easiest Nurse Midwife Programs to Get Into

2027 Easiest Nurse Midwife Programs to Get Into
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Fastest Online MSN in Health/Nursing Informatics Programs

2027 Fastest Online MSN in Health/Nursing Informatics Programs
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Florida: Online & Campus
2027 Easiest Nurse Practitioner Specialty Programs to Get Into

2027 Easiest Nurse Practitioner Specialty Programs to Get Into
2027 Best Online Associate in Health Sciences

2027 Best Online Associate in Health Sciences
2027 Is Nursing School Worth It?

2027 Is Nursing School Worth It?
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Most Affordable LVN to RN Online Bridge Programs

2027 Most Affordable LVN to RN Online Bridge Programs
2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2027 Most Affordable Online Direct Entry MSN Programs for Non-Nurses
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs
2027 Best Online Nurse Leadership DNP Programs

2027 Best Online Nurse Leadership DNP Programs
2027 Fastest Online MSN in Psychiatric Mental Health NP Programs

2027 Fastest Online MSN in Psychiatric Mental Health NP Programs
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus
September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees

September 2027 Best Online Certificate Program in Medical Office Administration: Guide to Online Degrees
2027 Most Affordable Online Master's Degrees in Nutrition

2027 Most Affordable Online Master's Degrees in Nutrition
2027 Cost of LPN Programs & Schools

2027 Cost of LPN Programs & Schools

Recently Published Articles

2027 How to Become a Pediatrician: Salary & Requirements

2027 How to Become a Pediatrician: Salary & Requirements
2027 Teacher Certification Types & Requirements in Idaho

2027 Teacher Certification Types & Requirements in Idaho
2027 Best Online Master’s in Gerontology Programs

2027 Best Online Master’s in Gerontology Programs
2027 Online Respiratory Care Therapy Degree Programs Costs: Tuition & Fees

2027 Online Respiratory Care Therapy Degree Programs Costs: Tuition & Fees
2027 How to Become a School Counselor in Oregon

2027 How to Become a School Counselor in Oregon
2027 How to Become a Forensic Scientist in Nevada

2027 How to Become a Forensic Scientist in Nevada
2027 Which Mathematics Degree Careers Offer the Best Work-Life Balance?

2027 Which Mathematics Degree Careers Offer the Best Work-Life Balance?
2027 How To Become a Community Health Worker: Salary & Career Paths

2027 How To Become a Community Health Worker: Salary & Career Paths
2027 AI Master's Degrees for Beginners With No Tech Background

2027 AI Master's Degrees for Beginners With No Tech Background
2027 Military-Friendly Online Political Science Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Political Science Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 How to Pay for a Nursing Informatics Master's Degree with Financial Aid

2027 How to Pay for a Nursing Informatics Master's Degree with Financial Aid
2027 How to Become a Substance Abuse Counselor in Oregon

2027 How to Become a Substance Abuse Counselor in Oregon
2027 Fastest Accredited Online Respiratory Care Therapy Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online Respiratory Care Therapy Programs: Accelerated Degrees and Completion Times
2027 How to Become a Mental Health Counselor in Port St. Lucie, FL: Education Requirements & Certification

2027 How to Become a Mental Health Counselor in Port St. Lucie, FL: Education Requirements & Certification
2027 Cost per Credit for Online Teaching Master's Programs: Tuition Comparison Guide

2027 Cost per Credit for Online Teaching Master's Programs: Tuition Comparison Guide
2027 How to Become a Substance Abuse Counselor in Tennessee

2027 How to Become a Substance Abuse Counselor in Tennessee
2027 Easiest Online Mechanical Engineering Bachelor's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Mechanical Engineering Bachelor's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 Online English Bachelor's Degree Completion Programs for Working Adults

2027 Online English Bachelor's Degree Completion Programs for Working Adults
2027 MD/MPH Dual Degree: Benefits, Career Paths & Salary

2027 MD/MPH Dual Degree: Benefits, Career Paths & Salary
2027 How to Pay for a Forensic Science Master's Degree with Financial Aid

2027 How to Pay for a Forensic Science Master's Degree with Financial Aid
2027 What Can You Do with a Biology Degree? Courses, Best Colleges, Careers & Salary

2027 What Can You Do with a Biology Degree? Courses, Best Colleges, Careers & Salary